# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-23-000008
Filing Date
2023-05-10
Accepted
2023-05-09 17:53:46
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nktr-20230331.htm iXBRL | 10-Q | 1050789
2 | EX-10.1 | nktr2023-03x31xexx1011.htm | EX-10.1 | 65358
3 | EX-31.1 | nktr2023-03x31xexx311.htm | EX-31.1 | 9524
4 | EX-31.2 | nktr2023-03x31xexx312.htm | EX-31.2 | 9517
5 | EX-32.1 | nktr2023-03x31xexx321.htm | EX-32.1 | 5893
11 |  | imagea.jpg | GRAPHIC | 3651
| Complete submission text file | 0000906709-23-000008.txt |  | 4924108

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20230331.xsd | EX-101.SCH | 37527
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20230331_cal.xml | EX-101.CAL | 66092
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20230331_def.xml | EX-101.DEF | 167926
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20230331_lab.xml | EX-101.LAB | 424573
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20230331_pre.xml | EX-101.PRE | 281405
50 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20230331_htm.xml | XML | 670859

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 23903617
SIC: 2834 Pharmaceutical Preparations